Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Aten Therapeutics Ltd
Aten Therapeutics Ltd is an active company incorporated on 7 October 2016 with the registered office located in Edinburgh, City of Edinburgh. Aten Therapeutics Ltd was registered 8 years ago.
Watch Company
Status
Active
Active since
3 years ago
Company No
SC547221
Private limited company
Scottish Company
Age
8 years
Incorporated
7 October 2016
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
16 October 2024
(10 months ago)
Next confirmation dated
16 October 2025
Due by
30 October 2025
(1 month remaining)
Last change occurred
3 years ago
Accounts
Submitted
For period
1 Oct
⟶
30 Sep 2024
(1 year)
Accounts type is
Total Exemption Full
Next accounts for period
30 September 2025
Due by
30 June 2026
(9 months remaining)
Learn more about Aten Therapeutics Ltd
Contact
Address
1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
Scotland
Same address for the past
5 years
Companies in EH3 9QA
Telephone
0131 3574251
Email
Unreported
Website
Oncobiopharm.com
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Wilfred Sydney Hanna
Director • British • Lives in England • Born in Apr 1967
Mr Ian Abercrombie
Director • Ceo • Scottish • Lives in Scotland • Born in Jun 1961
Oncobiopharm Limited
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Oncobiopharm Limited
Wilfred Sydney Hanna and Mr Ian Abercrombie are mutual people.
Active
Medannex Limited
Wilfred Sydney Hanna and Mr Ian Abercrombie are mutual people.
Active
Thirty Holdings Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Respiratory Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Therapeutics Limited
Wilfred Sydney Hanna is a mutual person.
Active
Edixomed Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Animal Health Limited
Wilfred Sydney Hanna is a mutual person.
Dissolved
Thirty Pharma Limited
Wilfred Sydney Hanna is a mutual person.
Dissolved
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
30 Sep 2024
For period
30 Sep
⟶
30 Sep 2024
Traded for
12 months
Cash in Bank
£433
Decreased by £26.94K (-98%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£5.32K
Decreased by £29.09K (-85%)
Total Liabilities
-£133.78K
Decreased by £46.28K (-26%)
Net Assets
-£128.46K
Increased by £17.19K (-12%)
Debt Ratio (%)
2515%
Increased by 1991.42% (+381%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
2 Months Ago on 23 Jun 2025
Confirmation Submitted
9 Months Ago on 28 Nov 2024
Full Accounts Submitted
1 Year 2 Months Ago on 25 Jun 2024
Confirmation Submitted
1 Year 10 Months Ago on 18 Oct 2023
Small Accounts Submitted
2 Years 2 Months Ago on 30 Jun 2023
Confirmation Submitted
2 Years 10 Months Ago on 17 Oct 2022
Accounting Period Shortened
3 Years Ago on 3 Aug 2022
Dormant Accounts Submitted
3 Years Ago on 27 Jul 2022
Mr Ian Abercrombie Appointed
3 Years Ago on 2 Feb 2022
Confirmation Submitted
3 Years Ago on 26 Oct 2021
Get Alerts
Get Credit Report
Discover Aten Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 30 September 2024
Submitted on 23 Jun 2025
Confirmation statement made on 16 October 2024 with no updates
Submitted on 28 Nov 2024
Total exemption full accounts made up to 30 September 2023
Submitted on 25 Jun 2024
Confirmation statement made on 16 October 2023 with no updates
Submitted on 18 Oct 2023
Accounts for a small company made up to 30 September 2022
Submitted on 30 Jun 2023
Confirmation statement made on 16 October 2022 with no updates
Submitted on 17 Oct 2022
Current accounting period shortened from 31 October 2022 to 30 September 2022
Submitted on 3 Aug 2022
Accounts for a dormant company made up to 31 October 2021
Submitted on 27 Jul 2022
Appointment of Mr Ian Abercrombie as a director on 2 February 2022
Submitted on 15 Feb 2022
Confirmation statement made on 16 October 2021 with updates
Submitted on 26 Oct 2021
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs